Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Artifactual isoform profile modification following treatment of human plasma or serum with protease inhibitor, monitored by 2-dimensional electrophoresis and mass spectrometry.

Schuchard MD, Mehigh RJ, Cockrill SL, Lipscomb GT, Stephan JD, Wildsmith J, Valdes-Camin R, Kappel WK, Rai AJ, Scott GB.

Biotechniques. 2005 Aug;39(2):239-47.

2.

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.

Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H, Schulz-Knappe P, Speicher DW, Vitzthum F, Haab BB, Siest G, Chan DW.

Proteomics. 2005 Aug;5(13):3262-77.

PMID:
16052621
3.

Expression of the plague plasminogen activator in Yersinia pseudotuberculosis and Escherichia coli.

Kutyrev V, Mehigh RJ, Motin VL, Pokrovskaya MS, Smirnov GB, Brubaker RR.

Infect Immun. 1999 Mar;67(3):1359-67.

4.
5.
6.

Expression of the low calcium response in Yersinia pestis.

Mehigh RJ, Sample AK, Brubaker RR.

Microb Pathog. 1989 Mar;6(3):203-17.

PMID:
2739560

Supplemental Content

Loading ...
Support Center